Over the last decade, Canada has been establishing itself a premier hub for innovative research in psychedelic research and neurotechnology, holding immense potential for revolutionizing mental health and neurological treatment. For emerging firms eager to make strides in the domain, navigating the financial landscape to fund such cutting-edge research can prove to be challenging. By […]


